119 related articles for article (PubMed ID: 37658685)
1. Modulatory effects of point-mutated IL-32θ (A94V) on tumor progression in triple-negative breast cancer cells.
Park HM; Park JY; Kim NY; Kim J; Pham TH; Hong JT; Yoon DY
Biofactors; 2024; 50(2):294-310. PubMed ID: 37658685
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer.
Pham TH; Bak Y; Kwon T; Kwon SB; Oh JW; Park JH; Choi YK; Hong JT; Yoon DY
Cell Commun Signal; 2019 May; 17(1):53. PubMed ID: 31126309
[TBL] [Abstract][Full Text] [Related]
3. IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer.
Bak Y; Kwon T; Bak IS; Hong J; Yu DY; Yoon DY
Oncotarget; 2016 Feb; 7(6):7307-17. PubMed ID: 26824417
[TBL] [Abstract][Full Text] [Related]
4. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
5. Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.
Yang HL; Thiyagarajan V; Shen PC; Mathew DC; Lin KY; Liao JW; Hseu YC
J Exp Clin Cancer Res; 2019 May; 38(1):186. PubMed ID: 31068208
[TBL] [Abstract][Full Text] [Related]
6. Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals.
Chen ZJ; Wei W; Jiang GM; Liu H; Wei WD; Yang X; Wu YM; Liu H; Wong CK; Du J; Wang HS
Mol Oncol; 2016 Jun; 10(6):775-88. PubMed ID: 26842883
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-32θ Triggers Cellular Senescence and Reduces Sensitivity to Doxorubicin-Mediated Cytotoxicity in MDA-MB-231 Cells.
Pham TH; Park HM; Kim J; Hong JT; Yoon DY
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067074
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.
Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C
J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262
[TBL] [Abstract][Full Text] [Related]
9. Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells.
Wang L; Tang C; Cao H; Li K; Pang X; Zhong L; Dang W; Tang H; Huang Y; Wei L; Su M; Chen T
Cancer Biol Ther; 2015; 16(8):1220-30. PubMed ID: 26121010
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA NKILA inhibited angiogenesis of breast cancer through NF-κB/IL-6 signaling pathway.
Luo LH; Rao L; Luo LF; Chen K; Ran RZ; Liu XL
Microvasc Res; 2020 May; 129():103968. PubMed ID: 31862380
[TBL] [Abstract][Full Text] [Related]
11. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
[TBL] [Abstract][Full Text] [Related]
12. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
Zhang X; Liu S; Zhu Y
Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Peptide RF16 Derived from CXCL8 Inhibits MDA-MB-231 Cell Invasion and Metastasis.
Chang CM; Chang CC; Lam HYP; Peng SY; Lai YH; Hsiang BD; Liao YY; Hsu HJ; Jiang SJ
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762330
[TBL] [Abstract][Full Text] [Related]
14. Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.
Tsubaki M; Komai M; Fujimoto S; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S
J Exp Clin Cancer Res; 2013 Sep; 32(1):62. PubMed ID: 24011086
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-8 upregulates integrin β3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-κB pathway.
Shao N; Lu Z; Zhang Y; Wang M; Li W; Hu Z; Wang S; Lin Y
Cancer Lett; 2015 Aug; 364(2):165-72. PubMed ID: 25979232
[TBL] [Abstract][Full Text] [Related]
17. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
18. DHEA inhibits proliferation, migration and alters mesenchymal-epithelial transition proteins through the PI3K/Akt pathway in MDA-MB-231 cells.
Colín-Val Z; López-Díazguerrero NE; López-Marure R
J Steroid Biochem Mol Biol; 2021 Apr; 208():105818. PubMed ID: 33508440
[TBL] [Abstract][Full Text] [Related]
19. Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-
Sun X; Chang X; Wang Y; Xu B; Cao X
Biomed Res Int; 2019; 2019():9241769. PubMed ID: 31341911
[TBL] [Abstract][Full Text] [Related]
20. Brazilein inhibits epithelial-mesenchymal transition (EMT) and programmed death ligand 1 (PD-L1) expression in breast cancer cells.
Wudtiwai B; Kodchakorn K; Shwe TH; Pothacharoen P; Phitak T; Suninthaboonrana R; Kongtawelert P
Int Immunopharmacol; 2023 May; 118():109988. PubMed ID: 36933493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]